Concepedia

Özlem Göker-Alpan

ÖG

Statistics

Publications

73

Citations

5.2K

H-Index

36

Active since

2002

Affiliations

Lysosomal and Rare Disorders Research and Treatment Center(Current)

O&O Alpan (United States)

National Human Genome Research Institute

National Institutes of Health

Duke Medical Center

Özlem Göker-Alpan is an author at Lysosomal and Rare Disorders Research and Treatment Center specializing in life sciences, gaucher disease, and enzyme replacement therapy.

ORCID

Publications per year

2002–2024

73

Publications

73

Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat

Dominique P. Germain, Derralynn Hughes, Daniel G. Bichet et al. · New England Journal of Medicine · 2016 · 556 citations · Full text

, , +17

Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study

Derralynn Hughes, Suma P. Shankar, Gere Sunder–Plassmann et al. · Journal of Medical Genetics · 2016 · 386 citations · Full text

, , +17

Parkinsonism among Gaucher disease carriers

Özlem Göker-Alpan · Journal of Medical Genetics · 2004 · 364 citations · Full text

, , +14

Glucocerebrosidase mutations are an important risk factor for Lewy body disorders

Özlem Göker-Alpan, Benoit I. Giasson, Michael J. Eblan et al. · Neurology · 2006 · 229 citations

, , +16

The Spectrum of Parkinsonian Manifestations Associated With Glucocerebrosidase Mutations

Özlem Göker-Alpan, Grisel Lopez, Joseph Vithayathil et al. · Archives of Neurology · 2008 · 196 citations · Full text

, , +17

1–5 of 73